Literature DB >> 29658920

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology.

Hailong Li1, Jessica M Illenberger1, Kristen A McLaurin1, Charles F Mactutus1, Rosemarie M Booze2.   

Abstract

In the central nervous system, the D1-alpha subtype receptor (Drd1α) is the most abundant dopamine (DA) receptor, which plays a vital role in regulating neuronal growth and development. However, the mechanisms underlying Drd1α receptor abnormalities mediating behavioral responses and modulating working memory function are still unclear. Using a novel RNA in situ hybridization assay, the current study identified dopamine Drd1α receptor and tyrosine hydroxylase (TH) RNA expression from DA-related circuitry in the nucleus accumbens (NAc) area and substantia nigra region (SNR), respectively. Drd1α expression in the NAc shows a "discrete dot" staining pattern. Clear sex differences in Drd1α expression were observed. In contrast, TH shows a "clustered" staining pattern. Regarding TH expression, female rats displayed a higher signal expression per cell relative to male animals. The methods presented here provide a novel in situ hybridization technique for investigating changes in dopamine system dysfunction during the progression of central nervous system diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29658920      PMCID: PMC5933265          DOI: 10.3791/57444

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

1.  Prefrontal dopamine D1 receptors and working memory in schizophrenia.

Authors:  Anissa Abi-Dargham; Osama Mawlawi; Ilise Lombardo; Roberto Gil; Diana Martinez; Yiyun Huang; Dah-Ren Hwang; John Keilp; Lisa Kochan; Ronald Van Heertum; Jack M Gorman; Marc Laruelle
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

2.  Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting.

Authors:  Stan B Floresco; Orsolya Magyar; Sarvin Ghods-Sharifi; Claudia Vexelman; Maric T L Tse
Journal:  Neuropsychopharmacology       Date:  2006-02       Impact factor: 7.853

3.  Dopamine D1 receptor subtype mediates acute stress-induced dendritic growth in excitatory neurons of the medial prefrontal cortex and contributes to suppression of stress susceptibility in mice.

Authors:  R Shinohara; M Taniguchi; A T Ehrlich; K Yokogawa; Y Deguchi; Y Cherasse; M Lazarus; Y Urade; A Ogawa; S Kitaoka; A Sawa; S Narumiya; T Furuyashiki
Journal:  Mol Psychiatry       Date:  2017-09-19       Impact factor: 15.992

4.  Dopaminergic Neurotransmission in the Nucleus Accumbens Modulates Social Play Behavior in Rats.

Authors:  Antonia Manduca; Michela Servadio; Ruth Damsteegt; Patrizia Campolongo; Louk Jmj Vanderschuren; Viviana Trezza
Journal:  Neuropsychopharmacology       Date:  2016-02-10       Impact factor: 7.853

5.  Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

Authors:  Y Okubo; T Suhara; K Suzuki; K Kobayashi; O Inoue; O Terasaki; Y Someya; T Sassa; Y Sudo; E Matsushima; M Iyo; Y Tateno; M Toru
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

Review 6.  The physiology, signaling, and pharmacology of dopamine receptors.

Authors:  Jean-Martin Beaulieu; Raul R Gainetdinov
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

7.  Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance.

Authors:  J Zahrt; J R Taylor; R G Mathew; A F Arnsten
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

8.  Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex.

Authors:  B A Ellenbroek; S Budde; A R Cools
Journal:  Neuroscience       Date:  1996-11       Impact factor: 3.590

Review 9.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

Review 10.  Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.

Authors:  Amy F T Arnsten; Ragy R Girgis; David L Gray; Richard B Mailman
Journal:  Biol Psychiatry       Date:  2016-01-18       Impact factor: 13.382

View more
  5 in total

1.  Detection and Quantification of Multiple RNA Sequences Using Emerging Ultrasensitive Fluorescent In Situ Hybridization Techniques.

Authors:  Larissa Erben; Andres Buonanno
Journal:  Curr Protoc Neurosci       Date:  2019-02-21

2.  S-EQUOL: a neuroprotective therapeutic for chronic neurocognitive impairments in pediatric HIV.

Authors:  Kristen A McLaurin; Hailong Li; Anna K Cook; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2020-09-01       Impact factor: 2.643

3.  Effects of chemogenetic manipulation of the nucleus accumbens core in male C57BL/6J mice.

Authors:  Kayla G Townsley; Marissa B Borrego; Angela R Ozburn
Journal:  Alcohol       Date:  2020-11-04       Impact factor: 2.405

4.  Single-Cell Quantification of mRNA Expression in The Human Brain.

Authors:  Sarah Jolly; Verena Lang; Viktor Hendrik Koelzer; Carlo Sala Frigerio; Lorenza Magno; Patricia C Salinas; Paul Whiting; Ernest Palomer
Journal:  Sci Rep       Date:  2019-08-26       Impact factor: 4.379

5.  Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders.

Authors:  Hailong Li; Kristen A McLaurin; Jessica M Illenberger; Charles F Mactutus; Rosemarie M Booze
Journal:  Viruses       Date:  2021-05-17       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.